EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

Maturitas

Volumn 73, Issue 2, 2012, Pages 171-174

  Rees, Margaret ^a   Pérez López, Faustino R ^b   Ceasu, Iuliana ^c,d   Depypere, Herman ^e   Erel, Tamer ^f   Lambrinoudaki, Irene ^g   Schenck Gustafsson, Karin ^h   Simoncini, Tommaso ⁱ   Van Der Schouw, Yvonne T ^j   Tremollieres, Florence ^k  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d CANTACUZINO INSTITUTE   (Romania)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f ISTANBUL UNIVERSITY   (Turkey)

^g UNIVERSITY OF ATHENS   (Greece)

^h UNIVERSITY OF PISA   (Italy)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k Paul Sabatier University   (France)

more..

Author keywords

Low dose; Postmenopausal; Vaginal atrophy; Vaginal estrogens

Indexed keywords

ESTROGEN;

ARTICLE; ATROPHY; FEMALE; HUMAN; PATHOLOGY; POSTMENOPAUSE; PRACTICE GUIDELINE; VAGINA; VAGINA DISEASE;

ATROPHY; ESTROGENS; FEMALE; HUMANS; POSTMENOPAUSE; VAGINA; VAGINAL DISEASES;

EID: 84873978361     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.06.009     Document Type: Article

References (30)

1. L.M. Pastore, R.A. Carter, B.S. Hulka, and E. Wells Self-reported urogenital symptoms in postmenopausal women: women's health initiative Maturitas 49 December (4) 2004 292 303 10.1016/j.maturitas.2004.06.019
2. R.E. Nappi, and M. Kokot-Kierepa Women's voices in the menopause: results from an international survey on vaginal atrophy Maturitas 67 November (3) 2010 233 238 10.1016/j.maturitas.2010.08.001
3. D.F. Archer Efficacy and tolerability of local estrogen therapy for urogenital atrophy Menopause 17 1 2010 194 203
4. T.L. Griebling, Z. Liao, and P.G. Smith Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women Menopause 19 6 2012 630 635
5. J. Suckling, A. Lethaby, and R. Kennedy Local oestrogen for vaginal atrophy in postmenopausal women Cochrane Database Systematic Reviews 18 October (4) 2006 CD001500
6. G. Bachmann, R.A. Lobo, R. Gut, L. Nachtigall, and M. Notelovitz Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial Obstetrics and Gynecology 111 1 2008 67 76
7. J. Simon, L. Nachtigall, R. Gut, E. Lang, D.F. Archer, and W. Utian Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet Obstetrics and Gynecology 112 5 2008 1053 1060
8. L.S. Ulrich, T. Naessen, D. Elia, J.A. Goldstein, and M. Eugster-Hausmann VAG-1748 trial investigators. Endometrial safety of ultra-low-dose Vagifem 10 mg in postmenopausal women with vaginal atrophy Climacteric 13 3 2010 228 237
9. J. Simon, L. Nachtigall, L.G. Ulrich, M. Eugster-Hausmann, and R. Gut Endometrial safety of ultra-low-dose estradiol vaginal tablets Obstetrics and Gynecology 116 4 2010 876 883
10. S.D. Reed, K.M. Newton, W.L. Clinton, M. Epplein, R. Garcia, and K. Allison Incidence of endometrial hyperplasia American Journal of Obstetrics and Gynecology 200 2009 678 686
11. M. Eugster-Hausmann, J. Waitzinger, and D. Lehnick Minimized estradiol absorption with ultra-low-dose 10 mg 17beta-estradiol vaginal tablets Climacteric 13 3 2010 219 227
12. H. Griesser, S. Skonietzki, T. Fischer, K. Fielder, and M. Suesskind Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol Maturitas 71 2012 360 368 10.1016/j.maturitas.2011.12.022
13. J.A. Chollet, G. Carter, L.A. Meyn, F. Mermelstein, and J.L. Balk Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis Menopause 16 2009 978 983
14. I. Santos, and S. Clissold Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy Gynecological Endocrinology 26 2010 644 651
15. L. Del Pup, D. Postruznik, and G. Corona Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study Maturitas 72 2012 93 94
16. M. Freedman, A.M. Kaunitz, K.Z. Reape, H. Hait, and H. Shu Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy Menopause 16 2009 735 741
17. D. Cella, L. Fallowfield, P. Barker, J. Cuzick, and A. Howell ATAC Trialists A9 Group Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer Breast Cancer Research and Treatment 100 2006 273 284
18. S. Loibl, A. Lintermans, A.S. Dieudonne, and P. Neven Management of menopausal symptoms in breast cancer patients Maturitas 68 2011 148 154
19. A. Kendall, M. Dowsett, E. Folkerd, and I. Smith Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors Annals of Oncology 17 2006 584 587
20. N. Biglia, E. Peano, and P. Sgandurra Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study Gynecological Endocrinology 26 2010 404 412
21. C.K. Mauck, D. Katz, and E.P. Sandefer Vaginal distribution of Replens and K-Y Jelly using three imaging techniques Contraception 77 2008 195 204
22. C.L. Loprinzi, S. Abu-Ghazaleh, and J.A. Sloan Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer Journal of Clinical Oncology 15 1997 969 973
23. M. Bygdeman, and M.L. Swahn Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women Maturitas 23 1996 259 263
24. J.A. van der Laak, L.M. de Bie, H. de Leeuw, P.C. de Wilde, and A.G. Hanselaar The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry Journal of Clinical Pathology 55 2002 446 451
25. D.J. Bateson, and E. Weisberg An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears Menopause 16 2009 765 769
26. New Zealand data sheet. Ovestin cream. http://www.msd-newzealand.com/products/pdf/Ovestinvagcrm.pdf [accessed 6.6.12].
27. R. Piccoli, V.D. Mandato, and G. Lavitola Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women: implications for management European Journal of Obstetrics, Gynecology, and Reproductive Biology 140 2008 269 274
28. British National Formulary. Topical HRT for vaginal atrophy. http://www.medicinescomplete.com/mc/bnf/current/4521.htm [accessed 12.6.12].
29. C. Maher, B. Feiner, K. Baessler, and C.M.A. Glazener Surgical management of pelvic organ prolapse in women Cochrane Database of Systematic Reviews 4. 2010 [art. no.: CD004014. DOI: 23676]
30. S.I. Ismail, C. Bain, and S. Hagen Oestrogens for treatment or prevention of pelvicorgan prolapse in postmenopausal women Cochrane Database Systematic Reviews September (9) 2010 CD007063